Sandoz Group (SDZNY) News Today $62.41 +6.50 (+11.63%) As of 08/7/2025 03:57 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesSEC FilingsShort InterestBuy This Stock SDZNY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Sandoz Group AG (SDZNY) Q2 2025 Earnings Call TranscriptAugust 7 at 12:08 PM | seekingalpha.comSandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarterAugust 7 at 2:00 AM | globenewswire.comSandoz Group (OTCMKTS:SDZNY) Shares Down 0.9% - Time to Sell?August 6 at 4:48 AM | marketbeat.comSandoz targets 70% price cut for weight-loss drugs in Canada, FT reportsAugust 4, 2025 | reuters.comSandoz to acquire Just-Evotec Biologics from Evotec for $300MJuly 30, 2025 | msn.comSandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, FranceJuly 30, 2025 | globenewswire.comSandoz Group (OTCMKTS:SDZNY) Sets New 52-Week High - Should You Buy?July 21, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Sets New 12-Month High - Time to Buy?July 14, 2025 | marketbeat.comSandoz Group AG (SDZNY) - Yahoo FinanceJuly 9, 2025 | finance.yahoo.comSandoz Group (OTCMKTS:SDZNY) Hits New 52-Week High - Here's WhyJuly 7, 2025 | marketbeat.comSDZNY - Sandoz Group AG ADR Dividends - MorningstarJuly 1, 2025 | morningstar.comMSandoz Group (OTCMKTS:SDZNY) Hits New 1-Year High - What's Next?June 30, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Trading Up 1.3% - Here's What HappenedJune 27, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Shares Gap Up - Here's What HappenedJune 18, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Hits New 1-Year High - Time to Buy?June 5, 2025 | marketbeat.comSandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]June 2, 2025 | globenewswire.comSandoz Group (OTCMKTS:SDZNY) Reaches New 1-Year High - Time to Buy?May 31, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Trading 1.6% Higher - Here's WhyMay 26, 2025 | marketbeat.comSandoz Group Ag Regulatory NewsMay 23, 2025 | lse.co.ukSandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilarsMay 21, 2025 | globenewswire.comSandoz Group AG (SDZNY) Q1 2025 Earnings Call TranscriptMay 2, 2025 | seekingalpha.comSandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmedApril 30, 2025 | globenewswire.comSandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indicationsApril 29, 2025 | globenewswire.comSandoz CEO slams EU-wide drug price proposal, warns US tariffs will hurt patient accessApril 28, 2025 | reuters.comRep. George Whitesides Sells Sandoz Group AG (OTCMKTS:SDZNY) StockApril 28, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Shares Down 1.3% - Time to Sell?April 25, 2025 | marketbeat.comSandoz shareholders approve all resolutions at Annual General MeetingApril 16, 2025 | markets.businessinsider.comShareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AGApril 15, 2025 | globenewswire.com[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the USApril 14, 2025 | globenewswire.comSwitzerland's Sandoz files antitrust lawsuit against Amgen in USApril 14, 2025 | reuters.comSandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the USApril 14, 2025 | globenewswire.comSandoz price target lowered to CHF 46.50 from CHF 50 at BarclaysApril 3, 2025 | markets.businessinsider.comSandoz Group AG (OTCMKTS:SDZNY) Short Interest UpdateApril 3, 2025 | marketbeat.comSandoz strengthens its balance sheet by issuing new bonds to repay spin-off term loans, and signs new USD 2 billion revolving credit facilityMarch 31, 2025 | globenewswire.comSandoz: Upgrading To A Buy On 2028 ExpectationsMarch 28, 2025 | seekingalpha.comSandoz Group AG (SDZXF)March 28, 2025 | finance.yahoo.comSandoz price target raised to CHF 44 from CHF 42 at RBC CapitalMarch 27, 2025 | markets.businessinsider.comBerenberg Bank Sticks to Their Hold Rating for Sandoz Group Ltd (SDZXF)March 18, 2025 | theglobeandmail.comSandoz Group Ltd (SDZXF) Gets a Buy from Kepler CapitalMarch 18, 2025 | theglobeandmail.comSandoz signs landmark supply and manufacturing agreementMarch 18, 2025 | globenewswire.comSandoz Group AG (OTCMKTS:SDZNY) Sees Significant Decrease in Short InterestMarch 13, 2025 | marketbeat.comSandoz price target lowered to CHF 38 from CHF 41 at Morgan StanleyMarch 12, 2025 | markets.businessinsider.comSandoz Group AG (SDZNY) (Q4 2024) Earnings Call Highlights: Record Sales and Strategic Growth ...March 6, 2025 | gurufocus.comSandoz Group: Sandoz reports strong FY 2024 results and Q4 2024 salesMarch 5, 2025 | finanznachrichten.deSandoz reports strong FY 2024 results and Q4 2024 salesMarch 4, 2025 | globenewswire.comAvecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in AustraliaMarch 3, 2025 | prnewswire.comSandoz Group AG (OTCMKTS:SDZNY) Short Interest Down 52.6% in FebruaryMarch 2, 2025 | marketbeat.comSandoz Group Ltd (SDZXF) Receives a Hold from UBSFebruary 28, 2025 | markets.businessinsider.comSandoz family foundation offers $3 billion worth of Novartis sharesFebruary 25, 2025 | reuters.comSandoz launches Pyzchiva in the U.S.February 24, 2025 | markets.businessinsider.com Get Sandoz Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SDZNY and its competitors with MarketBeat's FREE daily newsletter. Email Address SDZNY Media Mentions By Week SDZNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SDZNY News Sentiment▼0.550.39▲Average Medical News Sentiment SDZNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SDZNY Articles This Week▼41▲SDZNY Articles Average Week Get Sandoz Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SDZNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CHGCY News ZTS News DSNKY News TAK News ONC News SMMT News MKKGY News SGIOY News UTHR News NBIX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SDZNY) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sandoz Group AG Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Sandoz Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
